MYCBP2 抗体 (AA 60-100)
MYCBP2
适用: 人, 小鼠, 大鼠
IF (p), IHC (p)
宿主: 兔
Polyclonal
unconjugated
-
- 抗原 See all MYCBP2 抗体
- MYCBP2 (MYC Binding Protein 2 (MYCBP2))
-
抗原表位
- AA 60-100
- 适用
- 人, 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This MYCBP2 antibody is un-conjugated
-
应用范围
- Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 交叉反应
- 人, 小鼠, 大鼠
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human MYCBP2
- 亚型
- IgG
-
-
- 应用备注
-
IHC-P 1:200-400
IF(IHC-P) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
- 抗原
- MYCBP2 (MYC Binding Protein 2 (MYCBP2))
- 别名
- MYCBP2 (MYCBP2 产品)
- 别名
- AU023734 antibody, AW107953 antibody, AW546647 antibody, C130061D10Rik antibody, Pam antibody, Phr1 antibody, R75243 antibody, PAM antibody, MYC binding protein 2 antibody, MYC binding protein 2, E3 ubiquitin protein ligase antibody, Mycbp2 antibody, MYCBP2 antibody
- 背景
-
Synonyms: Pam/highwire/rpm-1 protein, Phr1, MYC binding protein 2, PAM, Pam, highwire, rpm 1, Protein associated with Myc, Probable E3 ubiquitin-protein ligase MYCBP2, Myc-binding protein 2, Pam/highwire/rpm-1 protein, Protein associated with Myc, MYCB2_HUMAN.
Background: MYCBP2 belongs to the highwire family. It is a probable E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins. MYCBP2 may function as a facilitator or regulator of transcriptional activation by MYC and have a role during synaptogenesis. There are two different isoforms.
- 基因ID
- 23077
- UniProt
- O75592
- 途径
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-
You are here:
